BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 31, Issue 47
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (28)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-1) series.
Item 
Count 
PDF6
HTML39
Figures (1-1)3
 Sum=48
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse10
Download13
 Sum=23
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse3
Download1
 Sum=4
Dec 21, 2025 (publication date) through Dec 19, 2025
Times Cited of This Article
  • Times Cited  (0)
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report
Copyright ©The Author(s) 2025.
World J Gastroenterol. Dec 21, 2025; 31(47): 113381
Published online Dec 21, 2025. doi: 10.3748/wjg.v31.i47.113381
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Summary of therapeutic changes and fecal calprotectin levels since initiation of mirikizumab. CF: Fecal calprotectin; Jan: January; Mar: March; Nov: November; Sep: September.
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345